141 related articles for article (PubMed ID: 25495979)
1. The potential of 12/15-lipoxygenase inhibitors in stroke therapy.
van Leyen K; Holman TR; Maloney DJ
Future Med Chem; 2014; 6(17):1853-5. PubMed ID: 25495979
[No Abstract] [Full Text] [Related]
2. Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.
Yigitkanli K; Pekcec A; Karatas H; Pallast S; Mandeville E; Joshi N; Smirnova N; Gazaryan I; Ratan RR; Witztum JL; Montaner J; Holman TR; Lo EH; van Leyen K
Ann Neurol; 2013 Jan; 73(1):129-35. PubMed ID: 23192915
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Karatas H; Eun Jung J; Lo EH; van Leyen K
Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
[TBL] [Abstract][Full Text] [Related]
4. Effects of ML351 and tissue plasminogen activator combination therapy in a rat model of focal embolic stroke.
Cheng G; Zhao W; Xin Y; Huang G; Liu Y; Li Z; Zhan M; Li Y; Lu L; van Leyen K; Liu Y
J Neurochem; 2021 May; 157(3):586-598. PubMed ID: 33481248
[TBL] [Abstract][Full Text] [Related]
5. Potent and selective inhibitors of human reticulocyte 12/15-lipoxygenase as anti-stroke therapies.
Rai G; Joshi N; Jung JE; Liu Y; Schultz L; Yasgar A; Perry S; Diaz G; Zhang Q; Kenyon V; Jadhav A; Simeonov A; Lo EH; van Leyen K; Maloney DJ; Holman TR
J Med Chem; 2014 May; 57(10):4035-48. PubMed ID: 24684213
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of isoflavones and isoflavans as potent inhibitors of human 12- and 15-lipoxygenases.
Mascayano C; Espinosa V; Sepúlveda-Boza S; Hoobler EK; Perry S
Chem Biol Drug Des; 2013 Sep; 82(3):317-25. PubMed ID: 23663316
[TBL] [Abstract][Full Text] [Related]
7. 12/15-Lipoxygenase Inhibition or Knockout Reduces Warfarin-Associated Hemorrhagic Transformation After Experimental Stroke.
Liu Y; Zheng Y; Karatas H; Wang X; Foerch C; Lo EH; van Leyen K
Stroke; 2017 Feb; 48(2):445-451. PubMed ID: 28057806
[TBL] [Abstract][Full Text] [Related]
8. Molecular-dynamics simulation of dioxygen egress from 12/15-lipoxygenase-arachidonic acid complex.
Pietra F
Chem Biodivers; 2012 Jun; 9(6):1019-32. PubMed ID: 22700222
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of 12/15 lipoxygenase by baicalein reduces myocardial ischemia/reperfusion injury via modulation of multiple signaling pathways.
Song L; Yang H; Wang HX; Tian C; Liu Y; Zeng XJ; Gao E; Kang YM; Du J; Li HH
Apoptosis; 2014 Apr; 19(4):567-80. PubMed ID: 24248985
[TBL] [Abstract][Full Text] [Related]
10. Baicalein is neuroprotective in rat MCAO model: role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2.
Cui L; Zhang X; Yang R; Liu L; Wang L; Li M; Du W
Pharmacol Biochem Behav; 2010 Oct; 96(4):469-75. PubMed ID: 20637223
[TBL] [Abstract][Full Text] [Related]
11. Cloning, purification and characterization of non-human primate 12/15-lipoxygenases.
Johannesson M; Backman L; Claesson HE; Forsell PK
Prostaglandins Leukot Essent Fatty Acids; 2010; 82(2-3):121-9. PubMed ID: 20106647
[TBL] [Abstract][Full Text] [Related]
12. The N-terminal β-barrel domain of mammalian lipoxygenases including mouse 5-lipoxygenase is not essential for catalytic activity and membrane binding but exhibits regulatory functions.
Walther M; Hofheinz K; Vogel R; Roffeis J; Kühn H
Arch Biochem Biophys; 2011 Dec; 516(1):1-9. PubMed ID: 21951814
[TBL] [Abstract][Full Text] [Related]
13. Novel lipoxygenase inhibitors as neuroprotective reagents.
van Leyen K; Arai K; Jin G; Kenyon V; Gerstner B; Rosenberg PA; Holman TR; Lo EH
J Neurosci Res; 2008 Mar; 86(4):904-9. PubMed ID: 17960827
[TBL] [Abstract][Full Text] [Related]
14. 5-Lipoxygenase and 12-lipoxygenase: attractive targets for the development of novel antipsoriatic drugs.
Müller K
Arch Pharm (Weinheim); 1994 Jan; 327(1):3-19. PubMed ID: 8117187
[No Abstract] [Full Text] [Related]
15. Effect of catechol derivatives on cell growth and lipoxygenase activity.
Simpson J; Forrester R; Tisdale MJ; Billington DC; Rathbone DL
Bioorg Med Chem Lett; 2003 Aug; 13(15):2435-9. PubMed ID: 12852938
[TBL] [Abstract][Full Text] [Related]
16. Identification of Protein Targets of 12/15-Lipoxygenase-Derived Lipid Electrophiles in Mouse Peritoneal Macrophages Using Omega-Alkynyl Fatty Acid.
Isobe Y; Kawashima Y; Ishihara T; Watanabe K; Ohara O; Arita M
ACS Chem Biol; 2018 Apr; 13(4):887-893. PubMed ID: 29461797
[TBL] [Abstract][Full Text] [Related]
17. Phenylalanine 353 is a primary determinant for the positional specificity of mammalian 15-lipoxygenases.
Borngräber S; Kuban RJ; Anton M; Kühn H
J Mol Biol; 1996 Dec; 264(5):1145-53. PubMed ID: 9000636
[TBL] [Abstract][Full Text] [Related]
18. Lipid metabolism: 5-lipoxygenase, 12/15-lipoxygenase, and atherogenesis.
Davidson J; Rotondo D
Curr Opin Lipidol; 2007 Feb; 18(1):107-9. PubMed ID: 17218838
[No Abstract] [Full Text] [Related]
19. Neuroprotection of early and short-time applying atorvastatin in the acute phase of cerebral ischemia: down-regulated 12/15-LOX, p38MAPK and cPLA2 expression, ameliorated BBB permeability.
Cui L; Zhang X; Yang R; Wang L; Liu L; Li M; Du W
Brain Res; 2010 Apr; 1325():164-73. PubMed ID: 20167207
[TBL] [Abstract][Full Text] [Related]
20. Regulation of bone mass in mice by the lipoxygenase gene Alox15.
Klein RF; Allard J; Avnur Z; Nikolcheva T; Rotstein D; Carlos AS; Shea M; Waters RV; Belknap JK; Peltz G; Orwoll ES
Science; 2004 Jan; 303(5655):229-32. PubMed ID: 14716014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
